Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ChiCTR |
Last refreshed on:
|
12 March 2018 |
Main ID: |
ChiCTR1800015158 |
Date of registration:
|
2018-03-11 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
A multicenter follow-up study of children's intestinal polyps in China
|
Scientific title:
|
A multicenter follow-up study of children's intestinal polyps in China |
Date of first enrolment:
|
2018-04-01 |
Target sample size:
|
Case series:426; |
Recruitment status: |
Pending |
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=25856 |
Study type:
|
Epidemilogical research |
Study design:
|
Cohort study
|
Phase:
|
Other
|
|
Countries of recruitment
|
China
| | | | | | | |
Contacts
|
Name:
|
Lan-Lan Geng
|
Address:
|
318 Renmin Road, Yuexiu District, Guangzhou, Guangdong, China
|
Telephone:
|
+86 13622237569 |
Email:
|
13622237569@163.com |
Affiliation:
|
Guangzhou Women and Children's Medical Center |
|
Name:
|
Shun-Xian Zhang
|
Address:
|
318 Renmin Road, Yuexiu District, Guangzhou, Guangdong, China
|
Telephone:
|
+86 15221367406 |
Email:
|
zhangshunxian110@163.com |
Affiliation:
|
Guangzhou Women and Children's Medical Center |
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: From April 1, 2018 to December 31, 2027, patients with intestinal polyps treated in the hospital department were selected.
Exclusion criteria: (1) the person who had not received the informed consent;
(2) exclude the subjects with insufficient fecal samples, insufficient blood volume or no collection, intestinal polyps, intestinal mucosa without collection, incomplete questionnaires or refusal to participate.
(3) all patients were excluded from tuberculosis, hepatitis B virus (HBV), hepatitis C virus (HCV), HIV and other viral infections, excluding other chronic diseases such as diabetes, hypertension and rheumatoid arthritis and other autoimmune diseases.
Age minimum:
0
Age maximum:
18
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Intestinal polyps
|
Intervention(s)
|
Case series:NA;
|
Primary Outcome(s)
|
Days of hospitalization;
|
Source(s) of Monetary Support
|
Self-financing
|
Ethics review
|
Status: Approved
Approval date:
Contact:
Li Qingfeng
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|